25.03.2013 Views

M. Letícia Ribeiro, CHC - Enerca

M. Letícia Ribeiro, CHC - Enerca

M. Letícia Ribeiro, CHC - Enerca

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>


LABORATORY DIAGNOSIS OF RARE<br />

ANAEMIAS<br />

Hereditary RBC membrane defects<br />

3rd European Symposium on Rare Anaemias<br />

M. Leticia <strong>Ribeiro</strong><br />

Madrid, Nov 2010<br />

M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>


Red Blood Cells<br />

RBCs are biconcave under<br />

physiological conditions<br />

Their shape changes when navigating<br />

narrow blood vessels or confined<br />

spaces in tissues and organs<br />

The ability of red cell to maintain its<br />

discoid shape, shape,<br />

elasticity and<br />

deformability in circulation, under<br />

constant mechanical shear and stress<br />

forces, is attributed to its lipid layer<br />

and proteins<br />

Kightley Media<br />

CELLS alive<br />

M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>


Erythrocyte Membrane Proteins<br />

Vertical Interaction<br />

Horizontal Interaction<br />

Lux SE, Palek J:<br />

Disorders of the Red Cell Membrane<br />

A deficiency of, or a dysfunction in, any one of these membrane<br />

proteins can weaken or destabilize the cytoskeleton, resulting<br />

in abnormal red cell morphology and a shorter life span -<br />

Hemolysis<br />

M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>


Red Blood Cell Membrane Disorders<br />

congenital hemolytic anemias characterized by clinical,<br />

laboratory and genetic heterogeneity<br />

Hereditary Spherocytosis<br />

Hereditary Elliptocytosis<br />

Hereditary Pyropoikilocytosis<br />

Hereditary Southeast Asian Ovalocytosis<br />

Hereditary Stomatocytosis<br />

M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>


Hereditary Stomatocytosis<br />

a group of dominantly inherited hemolytic anemias<br />

with abnormal membrane permeability to<br />

univalent cations<br />

Hydrocytosis – Overhydrated stomatocytosis<br />

Xerocytosis – Dehydrated stomatocytosis<br />

Cryohydrocytosis<br />

Familial Pseudohyperkaliemia<br />

M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>


Hereditary Elliptocytosis<br />

By Rex Graham<br />

Normal Pr 4.1 absent<br />

Skeletal network<br />

electron mycroscopy, by Yawata et al<br />

The main defects in HE are protein 4.1 deficiency and spectrin<br />

mutations, which can be detected as spectrin variants<br />

The clinical severity in HE depends on the amount of spectrin<br />

variant incorporated into the skeleton, and the closer the<br />

mutation is to the junction where dimers associate, the less<br />

stable is the tetramer<br />

M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>


Hereditary Elliptocytosis<br />

Prevalence<br />

1:5000 among Caucasians (Protein ( Protein 4.1 deficiency)<br />

deficiency<br />

1:100 in certain African countries (Spectrin ( Spectrin mutations)<br />

mutations)<br />

In the majority of HE individuals the anemia is very mild<br />

and often the elliptocytes are detected during a routine<br />

analysis<br />

Hb 7-9 g/dL<br />

Retic 11%<br />

Individuals Splenomegaly with nonhemolytic HE<br />

do not Protein<br />

have splenomegaly, splenomegaly<br />

4.1 deficiency<br />

, and<br />

their reticulocyte counts are slightly<br />

elevated to normal<br />

HE due to complete protein 4.1 deficiency is a severe<br />

hemolytic disease<br />

M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>


Pyropoikilocytosis<br />

HPP is a severe form of HE - patients often<br />

present with severe hemolytic anemia during the<br />

newborn period<br />

These patients are either homozygous or<br />

compound heterozygous for spectrin<br />

mutations<br />

HPP can also be due to the co-inheritance<br />

of the low-expression allele Spα LELY<br />

M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>


Pyropoikilocytosis<br />

D R S<br />

Hb g/dL<br />

MCV fL<br />

MCH pg<br />

M<strong>CHC</strong> %<br />

PBS<br />

14.1<br />

92<br />

29<br />

31<br />

Elliptocytes<br />

3º day of life<br />

Hb g/dL 11.5<br />

Bil mol/L 145<br />

Anisopoikylocytosis<br />

13.3<br />

13.4<br />

3 years old<br />

Normal<br />

αLELY αV/41 Spectrin α 28 Arg-His (CGT-CAT)<br />

α(nt 1857 Leu-Val; CTA-GTA) Intron 45, nt 12 (C-T)<br />

80<br />

30<br />

37<br />

96<br />

27<br />

29<br />

Normal<br />

Elliptocytes<br />

M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>


Southeast Asian Ovalocytosis<br />

Dominant inheritance<br />

SAO AE1 gene contains a deletion of 9 CD encoding amino<br />

acids 400-408, at the boundary of the cytoplasmic and<br />

membrane domains, in cis with Lys56Glu substitution<br />

SAO red cells are rigid and hiperstable<br />

Hemolysis is mild or absent<br />

Fem, 27 years old<br />

Pregnant<br />

Origin: East Timor<br />

Hb g/dL 11.1<br />

MCV fL 89<br />

MCH pg 31<br />

M<strong>CHC</strong> % 34.5<br />

RDW % 17<br />

M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>


Hereditary Spherocytosis<br />

Membrane lesions involving the vertical interactions<br />

between skeleton and lipid bilayer lead to vesiculation of the<br />

unsupported surface components, causing a progressive<br />

reduction in membrane surface area. area<br />

The red cell shape changes from a flexible, deformable biconcave<br />

disc to a spherical poorly deformable red cell – the<br />

spherocyte<br />

The severity of hemolysis depends on the contents of Spectrin<br />

from Lux SE, Palek J: Disorders of the Red Cell Membrane, Blood Principles and Pratice of Hematology<br />

M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>


Hereditary Spherocytosis<br />

The commonest cause of inherited chronic hemolysis in Northern<br />

Europe and North America - Prevalence 1:5000 to 1:2000<br />

Inheritance<br />

Dominant ≈ 2/3<br />

Non-dominant ≈ 1/3 de novo or recessive<br />

In Italian population the occurency of de novo dominant mutations in HS<br />

patients with normal parents is 6xs more common than recessive<br />

mutations (Miraglia del G. et al, 2001)<br />

The abnormal RBC morphology in HS is due to a deficiency of,<br />

or a disfunction in, Spectrin, Ankyrin, Band 3 and/or Protein 4.2<br />

The Spα LEPRA allele (Low Expression Prague) is prevalent among nondominant<br />

HS (Boivin, et al 1993, Dhermy, et al 2000, Wichterle, et al<br />

1996)<br />

M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>


HS – clinical features<br />

Clinical severity of HS varies from symptom-free carrier to severe<br />

hemolysis. Most individuals have mild to moderate disease<br />

The diagnosis may be made at any time of life<br />

Clinical manifestations:<br />

Neonatal jaundice / Intermittent jaundice<br />

Splenomegaly<br />

depending on the co-inherency of Gilbert syndrome<br />

Anemia<br />

Post-infection hemolytic anemia<br />

Aplastic crises (Parvovirus B19 infection)<br />

Excellent response to splenectomy<br />

Family history<br />

M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>


M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>


HS Laboratory Characteristics<br />

Anemia<br />

Reticulocytes ↑<br />

M<strong>CHC</strong> ↑<br />

% Hyperdense cells ↑<br />

Spherocytes<br />

Unconjugated ↑<br />

DAT neg<br />

M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>


120 fL<br />

60 fL<br />

Hyperchromic RBC<br />

Normal HS<br />

28 g/dL<br />

41 g/dL<br />

Methods: CBC+RET, CBC+RET,R<br />

CELL-DYN ® SAPPHIRE<br />

% hyperchromic RBC (<strong>CHC</strong> > 41g/dL)<br />

Samples:<br />

21 HS<br />

51 controls<br />

M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>


HS - hyperchromic RBC<br />

Statistical significant<br />

correlation between<br />

HS and % HPR RBC (>2.5%)<br />

Test Mann Whitney (U)<br />

Statistical significant association between<br />

HS and the typical scatter <strong>CHC</strong> Distribution (Test χ2 )<br />

U=1071<br />

p


HS - Diagnosis<br />

1. Screening tests<br />

Osmotic fragility<br />

AGLT (Pink test)<br />

Cryohemolysis<br />

Flow Cytometric (EMA)<br />

Ektacytometry<br />

2. Protein membrane<br />

electrophoresis<br />

3. Molecular studies<br />

M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>


Osmotic Fragility<br />

Spherocytes take up less water in a<br />

HS<br />

hypotonic solution before rupturing than<br />

entire do normal curve erythrocytes<br />

“shifted to the right”, or<br />

OF most gives of an it in indication the normal of the range volume-to- with a<br />

surface tail of fragile ratio cells<br />

curve Abnormal within OF normal invariably range indicates in 10-20% of<br />

abnormal cases red cells<br />

after OF 24h within incubation, the normal abnormalities range does not more<br />

mean marked, normal but red still cells with some falsenegative<br />

Practical Haematology, Dacie and Lewis, 10th Edition, 2006<br />

Parpart, et al 1947<br />

HS<br />

AIHH<br />

PK def.<br />

M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>


Acidified Glicerol Lyses-Time Test<br />

AGLT<br />

Time taken for 50%<br />

hemolysis of a blood sample<br />

in a buffered hypotonic<br />

saline-glycerol mixture<br />

Cells with a high volume-to-surface area ratio resist swelling<br />

for a shorter time than normal cells<br />

AGLT50:<br />

: HS 25’’-150’’; normal >30’<br />

AGLT 50<br />

HS: sensitivity 98.3%; specificity 91.1% (Hoffman et al)<br />

Short AGLT 50 in AIHA, HPFH, PK deficiency, severe G6PD,<br />

pregnant women (1:3), CRF on dialysis (some), MDS<br />

Special attention to the pH and osmolality<br />

PINK TEST (Bucx, et al 1988) is a modified AGLT<br />

Zanella, et al 1980<br />

ctr<br />

HS<br />

M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>


Cryohemolysis<br />

Dependent on factors related to red cell<br />

membrane molecular defects<br />

Normal 3-15%, HS >20%<br />

Increased hemolysis in HS and some CDAII<br />

and SAO<br />

For HS: sensitivity 95%; specificity 96% (Iglauer et<br />

al, 1999)<br />

Streichman and Gescheidt, 1998<br />

M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>


Flow Cytometric (Dye Binding) Test<br />

Measures the fluorescent intensity of intact red cells labeled with<br />

Eosin-5-Maleimide (EMA)<br />

EMA binds to Band 3 Lys430 (80%), Rh blood group proteins, Rh<br />

glycoprotein and CD47 (30%)<br />

EMA binding Flow Cytometric test is efficient for HS<br />

screening whatever the protein involved<br />

Reduced fluorescence in CDAII,<br />

cryohydrocytosis, SAO<br />

Fluorescence intensity graded reduction<br />

HPP< HS< HE≤ normal controls<br />

Each lab should set the reference range<br />

and cut-off values<br />

King, et al 2000<br />

F Girodon at al 2007<br />

For HS: sensitivity 92.7%; specificity 99.1% Gallagher M. Letícia PG, <strong>Ribeiro</strong>, Jarolim <strong>CHC</strong> P


Racio<br />

Diagnosis of HS by Flow Cytometry<br />

Department of Haematology - Centro Hospitalar de Coimbra<br />

n=181 - routine samples with normal hematological parameters;<br />

n=183 n= 183 - samples from previously diagnosed patient with Hemolytic<br />

Anemias (HA) of different types<br />

Mean ratios and the 95% CI for each group<br />

1.40<br />

1.20<br />

1.00<br />

0.80<br />

0.60<br />

1.08<br />

AIHA<br />

1.10<br />

nSHA<br />

0.98 <br />

1.00<br />

HMA<br />

Controls<br />

n=364<br />

<br />

HS<br />

0.71<br />

<br />

1.07 <br />

0.96<br />

Other HA<br />

HE<br />

Conclusions:<br />

HS have significantly different<br />

values from HA of other<br />

aetiology, in special AIHA<br />

HE values are quite similar to<br />

controls<br />

HS due to primary band 3<br />

deficiency and HS due to<br />

ankyrin/spectrin reduction have<br />

no significant different values<br />

M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>


Osmotic gradient Ektacytometry<br />

A laser diffraction viscometer that measures red<br />

cell deformability at constant shear stress as<br />

a continuous function of suspending<br />

osmolality (hypotonic to hypertonic)<br />

Results are plotted as a deformability curve,<br />

which has a distinct shape for each type of<br />

abnormal red cells tested<br />

Distinct deformability curves for red cells from<br />

patients with HS, HE, HPP, stomatocytosis<br />

and sickle disease<br />

Clark, et al 1983<br />

M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>


HS diagnosis - Screening tests<br />

Take into account the :<br />

sensitivity and specificity of the test<br />

complexity of the protocol<br />

cost of instruments and its maintenance<br />

More specific tests:<br />

Cryohemolysis – 95%<br />

EMA binding - 99 %<br />

(level IIa/III evidence, Grade B recommendation # )<br />

Confirmation of diagnosis may be necessary if the<br />

screening tests produce an equivocal or borderline<br />

result<br />

# Guidelines for the Diagnosis and Management of Hereditary Spherocytosis. General Haematology Task Force of the British Committee<br />

for Standards in Haematology, 2004. (modified from Iolascon et al 1998))<br />

M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>


Protein Membrane Electrophoresis SDS-PAGE<br />

SDS-PAGE Electrophoresis detects the qualitative and<br />

quantitative membrane proteins alterations<br />

Densitometry of the protein bands on the gel gives an overall<br />

profile of spectrins, spectrins,<br />

ankyrin, ankyrin,<br />

band 3 and protein 4.2<br />

Single ankyrin deficiency is not detectable in a non-<br />

splenectomised HS patient with reticulocytosis<br />

Laemmli<br />

α-spectrin -spectrin<br />

β-<br />

ankirin<br />

band 3<br />

prot.4.1<br />

prot.4.2<br />

actin<br />

G3PD<br />

stomatin<br />

Fairbanks<br />

M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>


Quantitation of membrane proteins<br />

Quantitation of membrane proteins is not necessary for the<br />

majority of HS cases<br />

Very mild or HS carrier states (≈10% of HS patients) may<br />

not have a detectable membrane protein deficiency<br />

In CDAII - a more compact and faster migrating Band 3<br />

In SAO - slower migrating Band 3<br />

SDS-PAGE is recommended when:<br />

the clinical phenotype is more severe than predicted from the<br />

red cell morphology<br />

the red cell morphology is more severe than predicted from<br />

parental blood films where one parent is known to have HS<br />

the diagnosis is not clear prior to splenectomy (MCV>100 fL)<br />

M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>


Hereditary Spherocytosis<br />

SM<br />

Normal<br />

Band 3 Coimbra<br />

488 (GTG - ATG) Val-Met<br />

Band 3 Mondego<br />

147 (CCT-TCT) Pro-Ser<br />

Band 3 Montefiori<br />

40(GAG-AAG) Glu-Lis<br />

Hb. g/dL<br />

MCV fL<br />

16.4<br />

99<br />

MCH pg<br />

M<strong>CHC</strong> %<br />

35<br />

34<br />

Spherocytes -<br />

Band N3<br />

Protein 4.2 N<br />

8.0<br />

94<br />

32<br />

34<br />

8.3<br />

88<br />

29<br />

33<br />

13,2<br />

98<br />

36<br />

36<br />

11.7<br />

83<br />

28<br />

34<br />

+++ +++<br />

-<br />

Additive effects of two unequally expressed<br />

↓ 39 ↓ 40<br />

N<br />

AE1 mutant alleles can aggravate the<br />

↓ 38 ↓ 36<br />

N<br />

clinical features of an affected individual<br />

+<br />

↓ 20<br />

↓ 18<br />

M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>


Molecular studies<br />

Almost 95% 95 of the HS-associated mutations identified were<br />

private or sporadic occurrences<br />

Knowledge of the gene mutation does not influence the<br />

clinical management of the patient<br />

Analysis of membrane protein genes<br />

to establish the genetic basis of variable clinical<br />

expressions among affected family members<br />

to confirm recessive or de novo dominant mutations<br />

when both parents are apparently normal<br />

for Prenatal diagnosis<br />

Prenatal diagnosis in families at risk of having a<br />

child with a very severe form of HS<br />

M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>


Family with dominant HS<br />

Hb g/dL 13.2 15.6<br />

MCV fL 94 95<br />

M<strong>CHC</strong> % 37 38<br />

Ret % ? ?<br />

Spherocytes ++ ++<br />

Band 3 ↓ 20% ↓ 21%<br />

Prot 4.2 ↓ 17% ↓ 18%<br />

Heterozygous Band 3 Coimbra<br />

AE1488 (GTG→ATG) (GTG ATG) Val→Met Val Met<br />

2 years before the couple had a<br />

stillborn baby (36 weeks of gestation)<br />

M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>


Family with dominant HS<br />

Hb g/dL 5.2<br />

MCV fL 147<br />

MCH pg 49<br />

M<strong>CHC</strong> % 49<br />

Erythroblasts x10 9 /L 102<br />

Platelets x10 9 /L 43<br />

Bil total mmol/L 99<br />

Bil unconj mmol/L 79<br />

Metabolic acidosis<br />

Hydropsis Fetalis<br />

36 weeks of gestation<br />

Laemmli 5% -15%<br />

NB ctr<br />

ctr<br />

Band 3<br />

Prot 4.2<br />

Homozygous Band 3 Coimbra<br />

AE1488 (GTG→ATG) (GTG ATG) Val→Met Val Met<br />

M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>


BSS - homozygous<br />

↓<br />

↓<br />

Father - heterozygous<br />

Prenatal Diagnosis<br />

Band 3 Coimbra<br />

488 (GTG→ATG)<br />

(GTG ATG)<br />

Fetus - heterozygous<br />

↓<br />

M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>


Flow chart for the diagnosis of HS<br />

Family History of HS;<br />

typical clinical & laboratory features<br />

No further<br />

investigations needed<br />

Dominant inheritance<br />

Patient presenting Hemolytic Anemia<br />

Variable clinical severity<br />

in different family members<br />

Search for co-inheriting<br />

hematological disorders<br />

β-Thalassemia or<br />

Sickle Cell Disease<br />

None<br />

Atypical blood film, ?<br />

Recent infection; no family history of HS<br />

Screen proband family<br />

for abnormal RBCs<br />

HS RBCs indicated<br />

in proband & sibling<br />

Normal test<br />

results<br />

Not membrane<br />

SDS-PAGE for<br />

protein defect ? Thalassemia<br />

? CDA ? MDS<br />

DNA analysis for low-expression allele (mainly αSp)<br />

Recessive or non-dominant inheritance<br />

in proband with no family history<br />

Guidelines for the Diagnosis and Management of Hereditary Spherocytosis. General Haematology Task Force of<br />

the British Committee for Standards in Haematology, 2004. (modified from Iolascon et al M. 1998)) Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>


References<br />

1. Guidelines for the Diagnosis and Management of Hereditary Spherocytosis. P.H.B.<br />

Bolton-Maggs, R. F. Stevens, N.J. Dodd, M-J. King, G. Lamont, Pl Tittensor, On behalf<br />

of the General Haematology Task Force of the British Committee for Standards in<br />

Haematology, 2004<br />

2. Red Cell Membrane Disorders, Patrick G. Gallagher, Hematology 2005, The American<br />

Society of Hematology<br />

3. Practical Haematology, Dacie and Lewis, 10th ed. 2006 Churchill Livingstone<br />

4. Hematology of Infancy and Childhood, Nathan and Oski's, Sixth Edition by David G.<br />

Nathan, Stuart H. Orkin, A. Thomas Look, David Ginsburg<br />

5. Cryohemolysis test as a diagnostic tool for hereditary spherocytosis, A. Iglauer D.<br />

Reinhardt W. Schröter A. Pekrun, Ann Hematol (1999) 78: 555–557<br />

6. Anaemia, a defective cytoskeleton and cation permeability, May-Jean King,<br />

International Blood Group, Reference Laboratory, Southmead, Bristol, Biomedical<br />

Science Congress<br />

7. Diagnostic utility of the pre-incubated acidified glycerol lysis test in haemolytic and<br />

non-haemolytic anaemias.Hoffmann JJ, Swaak-Lammers N, Breed WP, Strengers JL.<br />

Eur J Haematol. 1991 Nov;47(5):367-70<br />

8. Usefulness of the eosin-5'-maleimide cytometric method as a first-line screening test<br />

for the diagnosis of hereditary spherocytosis: comparison with ektacytometry and<br />

protein electrophoresis. Girodon F, Garçon L, Bergoin E, Largier M, Delaunay J,<br />

Fénéant-Thibault M, Maynadié M, Couillaud G, Moreira S, Cynober. T. Br J Haematol.<br />

2008 Feb;140(4):468-70<br />

M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>


Unidade de Anemias Congénitas<br />

Centro Hospitalar de Coimbra<br />

Celeste Bento<br />

Helena Almeida<br />

Elizabete Cunha<br />

Janet Pereira<br />

Umbelina Rebelo<br />

Luís Relvas<br />

www.chc-hematologia.org<br />

M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!